Page last updated: 2024-08-24

cilazapril, anhydrous and Primary Peritonitis

cilazapril, anhydrous has been researched along with Primary Peritonitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, JL; Hao, JB; Hao, LR; Ren, LS; Zhang, L1

Other Studies

1 other study(ies) available for cilazapril, anhydrous and Primary Peritonitis

ArticleYear
The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
    Laboratory investigation; a journal of technical methods and pathology, 2014, Volume: 94, Issue:8

    Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Cilazapril; Dialysis Solutions; Disease Models, Animal; Drug Therapy, Combination; Lymphocytes; Macrophages; Male; Mineralocorticoid Receptor Antagonists; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Fibrosis; Peritoneum; Peritonitis; Random Allocation; Rats; Rats, Wistar; Receptors, Mineralocorticoid; Spironolactone; Transforming Growth Factor beta1

2014